The Valley Desk

NCT05176483 · Interventional trial

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Overall registry status Recruiting

Phase 1

Conditions Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI), Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatocellular Carcinoma (HCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Clear Cell Renal Cell Carcinoma (nccRCC), Non-small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Solid Tumor, Urothelial Carcinoma (UC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov